n00_be

jadi orang cukup bukan orang kaya⚙️⚙️⚙️⚙️

[n00_be @n00_be]

@jyontara @Mailamala1

[Pebble Mayhem | Mint: TODAY @PebbleMayhem]

Whitelist registration is now live.

🔗 https://t.co/qG2s23kWno

Built for real gameplay.
Designed to evolve with its ecosystem.

✦ Ecosystem Revenue Share
✦ Dynamic On-Chain Progression
✦ Fully Integrated Gameplay

The Hell Fungus is spreading.
Prepare for absolute mayhem.

[Pebble Mayhem | Mint: TODAY @PebbleMayhem]

Whitelist registration is now live.

🔗 https://t.co/qG2s23kWno

Built for real gameplay.
Designed to evolve with its ecosystem.

✦ Ecosystem Revenue Share
✦ Dynamic On-Chain Progression
✦ Fully Integrated Gameplay

The Hell Fungus is spreading.
Prepare for absolute mayhem.

[Knidos @knidosxyz]

TESTNET LIVE

Knidos testnet is here.

The first onchain AI fund manager verifiable by anyone, trusted by no one.

If you're not sure whether you have access, read this thread. Three ways in, one waitlist for everyone else.

↓

[n00_be @n00_be]

I joined Knidos testnet and I am exploring autonomous on-chain trading agent.
Join the waitlist now:
https://t.co/htYTu8DI4A

#Knidos #Testnet

[KieDex @kiedexapp]

https://t.co/ZDxNr887cA

[KieDex @kiedexapp]

KieDex reaches 10,000 users worldwide within 24 hours of launch.

A strong start powered by real community growth and engagement.

Join now: https://t.co/LRMDbMSEOC

This is only the beginning.
#Kiedex #KDX #10K #BASE

[n00_be @n00_be]

@TempoAgentz My EVM Wallet: 0xc936A819E18fD62602b5b24C0fC7E3fe8A3031eA

[n00_be @n00_be]

Follow @tempoagentz , the steps on https://t.co/BBRk8CJTkY and secure your WL Free Mint. https://t.co/3t7pYou50z

[n00_be @n00_be]

First Q-CHIP. Now Keycard

Slowly building my footprint on @dac_chain with Clearance Level 1 and 451 QE.

Get yours here, it's free: https://t.co/ESbBQLyMYJ

[LIFE AI @LifeNetwork_AI]

🩺 Community Question: Is the “AI five layer cake” framework sufficient to power healthcare AI systems?

(The “AI five layer cake” framework: Energy → Chips → Infrastructure → Models → Applications, introduced by Jensen Huang of NVIDIA)

Viewpoint A: Yes
Healthcare AI aligns with the stack. Energy, chips, and infrastructure enable intelligence generation at scale. Medical models, trained on clinical and biomedical data, interpret complex signals; applications then deliver value through radiology assistance, drug discovery, and clinical workflow automation.

Viewpoint B: Not entirely
The stack shows how capability is produced, but impact depends on translating that capability into clinical use. Strict validation, regulation, and the need to integrate with hospital workflows slow translation; consequently, healthcare applications often scale more slowly than the underlying AI stack.

👇Drop A or B and share your perspective

[n00_be @n00_be]

Discover a new era of healthcare with LifeAI.
@LifeNetwork_AI #LifeAI #healthcareAI https://t.co/dcN5hwDFtY

[LIFE AI @LifeNetwork_AI]

🩺 Community Question: Is the “AI five layer cake” framework sufficient to power healthcare AI systems?

(The “AI five layer cake” framework: Energy → Chips → Infrastructure → Models → Applications, introduced by Jensen Huang of NVIDIA)

Viewpoint A: Yes
Healthcare AI aligns with the stack. Energy, chips, and infrastructure enable intelligence generation at scale. Medical models, trained on clinical and biomedical data, interpret complex signals; applications then deliver value through radiology assistance, drug discovery, and clinical workflow automation.

Viewpoint B: Not entirely
The stack shows how capability is produced, but impact depends on translating that capability into clinical use. Strict validation, regulation, and the need to integrate with hospital workflows slow translation; consequently, healthcare applications often scale more slowly than the underlying AI stack.

👇Drop A or B and share your perspective

[LIFE AI @LifeNetwork_AI]

🩺 Community Question
Is blockchain ready for healthcare infrastructure at scale?

Viewpoint A: Structural barriers remain.
Blockchain still struggles with scalability for large health datasets, integration with legacy hospital systems, and regulatory compliance. Operational adoption remains limited, with most initiatives still at the pilot stage.

Viewpoint B: The technology is maturing.
New blockchain architectures are improving speed, efficiency, and scalability. Hybrid models are advancing interoperability with existing healthcare systems. Early pilots also show progress toward secure, patient controlled data sharing.

👇 Comment A or B and share your perspective.

[LIFE AI @LifeNetwork_AI]

🩺 Community Question:
Healthcare is a paradox: trillions spent and cutting-edge technology, why is humanity only getting sicker?

Viewpoint A: The healthcare system is broken (reactive, wasteful, poorly coordinated).
The system prioritizes treatment over prevention, carries massive administrative waste, and fails to use advanced technology efficiently. The result is high spending and weak outcomes.

Viewpoint B: The real drivers lie outside healthcare (social factors, lifestyle, inequality).
Healthcare accounts for only a small share of health outcomes. Poverty, obesity, unhealthy lifestyles, and inequality are the root causes. Increasing medical spending alone does not address the core problem.

👇 Drop A or B and share your perspective

[n00_be @n00_be]

Intelligent care for a healthier tomorrow-LifeAI.
@LifeNetwork_AI #LifeAI #healthcareAI https://t.co/jwRJe1d0gE

[LIFE AI @LifeNetwork_AI]

🩺 Community Question:
In medical innovation, what drives greater long-term impact:
U.S.-grade quality for rigorous validation and strict regulation
or Asia-speed execution for faster approvals and rapid scale?

Viewpoint A: U.S.-Grade Quality
Through institutions like the U.S. Food and Drug Administration, the U.S. emphasizes deep clinical validation before approval.
Rigor reduces risk, protects trust, and supports durable breakthrough innovation.

Viewpoint B: Asia-Speed Execution
Countries such as China and India accelerate approvals and deploy innovations at scale.
Faster access can save lives, especially in high-burden diseases.

👇 Drop A or B and share your perspective.

[LIFE AI @LifeNetwork_AI]

🩺 Community Question:
In medical innovation, what drives greater long-term impact:
U.S.-grade quality for rigorous validation and strict regulation
or Asia-speed execution for faster approvals and rapid scale?

Viewpoint A: U.S.-Grade Quality
Through institutions like the U.S. Food and Drug Administration, the U.S. emphasizes deep clinical validation before approval.
Rigor reduces risk, protects trust, and supports durable breakthrough innovation.

Viewpoint B: Asia-Speed Execution
Countries such as China and India accelerate approvals and deploy innovations at scale.
Faster access can save lives, especially in high-burden diseases.

👇 Drop A or B and share your perspective.

[XBIT @XBITDEX]

🎆 XBIT Lunar New Year Red Packet Carnival is Coming!
🧧 68,888 USDC in New Year Red Packets!

This year, no empty wishes — we’re sending real USDC 💰

🎁 The Breakdown:
📦 Main Pool: 65,000 USDC
🌟 888 USDC Super Lucky Packets ×2
📣 Share-to-Earn: 2,000 USDC
📅 Feb 16 – Feb 24 (9 Days Straight)
🧧 Link: https://t.co/xgAgNmRY7u

[n00_be @n00_be]

Your ideas can push healthcare forward.
Add them here.
Join: https://t.co/KFbDEMbvFd
Code: 2OEOUKV
#LifeAITestnet #HealthcareAI

[LIFE AI @LifeNetwork_AI]

🩺 Community Question:
Elon Musk recently said that, based on current human constraints, AI-powered robotics could become better surgeons than the best human surgeons within three years at scale.

Do you agree with him?

Viewpoint A:
Agree. With few great surgeons, slow and costly human training, and unavoidable human error, AI and robotics could learn faster and scale surgical skill beyond human limits.

Viewpoint B:
Disagree. Even acknowledging the human constraints Elon Musk points out, surgery is not only about speed, scale, or error reduction. It also depends on judgment, responsibility, and trust in high-stakes situations, which remain difficult to validate and deploy safely at scale.

Is this a near-term breakthrough or a vision that overestimates how quickly surgical autonomy can be safely scaled?

👇 Drop A, B, or share your perspective.

[LIFE AI @LifeNetwork_AI]

💊 Community Question:
Can AI help discover and develop new medicines much faster and cheaper than traditional methods?

Viewpoint A:
Yes. AI can rapidly test millions of drug ideas, cut early research time and costs dramatically, and in some cases bring medicines to patients years faster.

Viewpoint B:
Not fully. AI helps at the start, but human trials are still slow, expensive, and unpredictable, keeping overall drug development costly and time-consuming.

If AI is expected to change how medicines are made, is the impact already real or mostly promise?

👇 Drop A, B, or share your perspective.

[n00_be @n00_be]

Smarter health decisions start with @LifeNetwork_AI.
#healthcareAI #LifeAI https://t.co/djCXbGMXRP

[LIFE AI @LifeNetwork_AI]

💊 Community Question:
Can AI help discover and develop new medicines much faster and cheaper than traditional methods?

Viewpoint A:
Yes. AI can rapidly test millions of drug ideas, cut early research time and costs dramatically, and in some cases bring medicines to patients years faster.

Viewpoint B:
Not fully. AI helps at the start, but human trials are still slow, expensive, and unpredictable, keeping overall drug development costly and time-consuming.

If AI is expected to change how medicines are made, is the impact already real or mostly promise?

👇 Drop A, B, or share your perspective.